Ipca Laboratories Limited
IPCALAB
Clasificación en acciones
#3411
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Precio por acción
$20.00
Capitalización bursátil
$5.08B
Cambio (1 día)
-1.76%
Cambio (1 año)
36.89%
País
IN
Comercio Ipca Laboratories Limited (IPCALAB)
Categoría
Healthcare
EPS de Ipca Laboratories Limited (IPCALAB)
EPS a fecha de June 2026 TTM: $0.57
Según los últimos informes financieros y el precio de las acciones de Ipca Laboratories Limited, el EPS actual de la empresa (TTM) es $0.57. Al final del año 2024, la empresa tenía un EPS de $0.26 un aumento con respecto a al EPS de 2023, que fue de $0.23.
Historial de EPS de Ipca Laboratories Limited desde 2005 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $0.57 | 67.59% |
| 2025 | $0.34 | 31.43% |
| 2024 | $0.26 | 14.42% |
| 2023 | $0.23 | -50.75% |
| 2022 | $0.46 | -25.34% |
| 2021 | $0.61 | 93.12% |
| 2020 | $0.32 | 25.55% |
| 2019 | $0.25 | 73.94% |
| 2018 | $0.15 | 22.62% |
| 2017 | $0.12 | 113.46% |
| 2016 | $0.06 | -65.49% |
| 2015 | $0.16 | -48.97% |
| 2014 | $0.32 | 34.08% |
| 2013 | $0.24 | 8.86% |
| 2012 | $0.22 | -7.87% |
| 2011 | $0.24 | 28.52% |
| 2010 | $0.18 | 131.65% |
| 2009 | $0.08 | -41.78% |
| 2008 | $0.14 | 16.48% |
| 2007 | $0.12 | 111.05% |
| 2006 | $0.06 | -18.58% |
| 2005 | $0.07 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -2.37% |
IN
|
